Mereo’s Alvelestat Shows Encouraging Biomarker Data In Bronchiolitis Obliterans Syndrome
Mereo BioPharma Group plc (NASDAQ:MREO) has announced data from an interim analysis of an investigator-initiated study of alvelestat, in patients with…
Seres Therapeutics Gets FDA Green Signal to Start SER-155 Human Trials
The FDA has signed off Seres Therapeutics Inc’s (NASDAQ:MCRB) Investigational New Drug (IND) application for SER-155 to initiate Phase 1 trial.…
BeyondSpring’s Plinabulin US Application for Chemo-Induced Neutropenia Under Review
The FDA has accepted for review BeyondSpring Inc’s (NASDAQ:BYSI) marketing application seeking approval for the use of plinabulin in combination with…
Akebia Therapeutics Stock Jumps as FDA Accepts Vadadustat US Application in CKD-Related Anemia
Akebia Therapeutics Inc (NASDAQ:AKBA) and its collaborator Otsuka Holdings (OTC:OTSKY) have announced that the FDA has accepted to review vadadustat’s marketing application for…
Sanofi Stops Venglustat Development In Rare Genetic Kidney Disorder
Sanofi SA (NASDAQ:SNY) has halted the clinical program of venglustat in autosomal dominant polycystic kidney disease (ADPKD). Although the safety profile…
Amgen’s First KRAS-Targeted Therapy, Lumakras Scores FDA Approval For Lung Cancer
The FDA has given accelerated approval to Amgen Inc’s (NASDAQ:AMGN) Lumakras (sotorasib) for non-small cell lung cancer (NSCLC) patients harboring kras mutation.…
Companies, Government Agencies Use Lavish Sweepstakes Prizes To Increase COVID-19 Vaccinations
With less than half of the U.S. population receiving the full dosages of the COVID-19 vaccine, several companies and state governments are still trying to speed the progress of national inoculations by offering extravagant sweepstakes prizes for those who have become fully vaccinated.
European Drug Regulator Supports Use Of Pfizer-BioNTech COVID-19 Vaccine In Adolescents: Reuters
European Medical Agency backed the use of Pfizer Inc (NYSE:PFE) – BioNTech SE’s (NASDAQ:BNTX) COVID-19 vaccine for children as young as 12,…